The short version
6 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 19% over the past year, to $0.7198 per mL. One of its named manufacturing plants, Nephron SC, LLC, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.